CVS Health Co. (NYSE:CVS) Stock Holdings Decreased by Moran Wealth Management LLC

Moran Wealth Management LLC decreased its position in CVS Health Co. (NYSE:CVS) by 77.1% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 38,205 shares of the pharmacy operator’s stock after selling 128,902 shares during the period. Moran Wealth Management LLC’s holdings in CVS Health were worth $2,402,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in CVS. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health during the third quarter valued at $25,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health in the 3rd quarter valued at about $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health in the third quarter worth approximately $32,000. Kathleen S. Wright Associates Inc. acquired a new stake in shares of CVS Health during the third quarter worth approximately $33,000. Finally, First Community Trust NA increased its stake in CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 302 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Up 0.4 %

Shares of CVS opened at $57.07 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The stock has a market cap of $71.81 billion, a price-to-earnings ratio of 14.48, a P/E/G ratio of 0.94 and a beta of 0.55. CVS Health Co. has a 12 month low of $52.71 and a 12 month high of $83.25. The company has a 50-day moving average price of $59.20 and a two-hundred day moving average price of $58.60.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business’s revenue was up 6.3% on a year-over-year basis. During the same period last year, the business earned $2.21 earnings per share. Equities analysts predict that CVS Health Co. will post 5.43 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.66%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s payout ratio is currently 67.51%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. Royal Bank of Canada lowered their price target on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday, November 15th. TD Cowen raised CVS Health from a “hold” rating to a “buy” rating and raised their price target for the stock from $59.00 to $85.00 in a research note on Friday, October 4th. Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. Evercore ISI lifted their target price on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. Finally, Mizuho dropped their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $72.28.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.